1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PRIME MEDICINE INC
Prime Medicine Inc XNAS: PRME
4.27 0.16 (3.89%)
576.3K
XNAS Volume

XNAS 10 Mar, 2026 10:33 AM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Prime Medicine Inc is on 11 Mar 2026 for the purpose of The Citizens Life Sciences Conference See details

Prime Medicine Inc - PRME - stock price prediction, stock price target, analyst ratings from 12 analysts

Prime Medicine Inc has a share price target of US$ 6, revenue growth forecast of 91.3%, and profit growth estimate of -2.0% for FY25, based on top 12 analyst calls.